These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
362 related items for PubMed ID: 9721542
1. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria]. Yamane N, Nakasone I, Saitoh H, Kaneda M, Shimojima M, Yamashita K, Toyoda K, Okazawa Y. Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542 [Abstract] [Full Text] [Related]
2. [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria]. Yamane N, Onaga S, Saitoh H, Toyoshima S, Shimojima M, Kawahara S, Takashima T, Yamashita T. Rinsho Byori; 2002 Apr; 50(4):381-91. PubMed ID: 12014018 [Abstract] [Full Text] [Related]
3. [Multicenter evaluation of broth microdilution test, BrothMIC MTB, to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for Mycobacterium tuberculosis--evaluation of interlaboratory precision and interpretive compatibility with agar proportion method]. Yamane N, Ichiyama S, Kawahara S, Iinuma Y, Saitoh H, Shimojima M, Udagawa H, Nakasone I. Rinsho Byori; 1999 Aug; 47(8):754-66. PubMed ID: 10511808 [Abstract] [Full Text] [Related]
4. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate]. Yamazaki T, Sato N, Yamashita K, Okazawa Y, Miyao H, Tanno K. Rinsho Byori; 1999 Feb; 47(2):170-5. PubMed ID: 10097635 [Abstract] [Full Text] [Related]
5. [Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test]. Yamane N, Nakasone I, Yamashita K, Toyoda K, Okazawa Y. Rinsho Byori; 1998 May; 46(5):479-85. PubMed ID: 9627500 [Abstract] [Full Text] [Related]
6. [Interpretive compatibility of antimycobacterial susceptibility for Mycobacterium tuberculosis determined by proportion test method on egg-based Ogawa media and broth microdilution test, BrothMIC MTB]. Higa M, Saitoh H, Yamane N, Nakasone I, Miyagi C. Kekkaku; 2002 Feb; 77(2):61-6. PubMed ID: 11905029 [Abstract] [Full Text] [Related]
7. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice]. Tomioka H, Sato K, Saito H. Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119 [Abstract] [Full Text] [Related]
8. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM]. Kawata N, Kawahara S, Tada A, Takigawa N, Shibayama T, Soda R, Takahashi K. Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941 [Abstract] [Full Text] [Related]
9. [Reliability of bioluminescent assay (ATP method) for testing antimicrobial susceptibility of Mycobacterium tuberculosis]. Yamazaki T, Sato N, Yamashita K, Okazawa Y, Araki H, Miwa A. Rinsho Byori; 2003 Mar; 51(3):194-200. PubMed ID: 12707990 [Abstract] [Full Text] [Related]
10. [Chemotherapy of pulmonary Mycobacterium kansasii infection]. Mizutani S. Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388 [Abstract] [Full Text] [Related]
11. [Drug susceptibility test for Mycobacterium tuberculosis using non-radioactive substance, alpha-antigen]. Shigeto E, Taska H. Kekkaku; 1996 Mar; 71(3):245-52. PubMed ID: 8901226 [Abstract] [Full Text] [Related]
12. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry. Akselband Y, Cabral C, Shapiro DS, McGrath P. J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276 [Abstract] [Full Text] [Related]
13. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments]. Tsukamura M. Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817 [Abstract] [Full Text] [Related]
14. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by the bioluminescence assay of mycobacterial ATP using filamentous cell treatment]. Yamazaki T, Sato N, Yamashita K, Okazawa Y, Tanno K. Rinsho Byori; 2000 Feb; 48(2):167-73. PubMed ID: 10804821 [Abstract] [Full Text] [Related]
15. [Multicenter evaluation of a colorimetric microplate antimycobacterial susceptibility test: comparative study with the NCCLS M24-P]. Yamane N, Oiwa T, Kiyota T, Saitoh H, Sonoda T, Tosaka M, Nakashima M, Fukunaga H, Masaki T, Miyagawa K, Miyagoe M, Okazawa Y. Rinsho Byori; 1996 May; 44(5):456-64. PubMed ID: 8676566 [Abstract] [Full Text] [Related]
16. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests]. Yamamoto S, Toida I, Watanabe N, Ura T. Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227 [Abstract] [Full Text] [Related]
17. [Antimycobacterial activities of a new quinolone, sparfloxacin]. Tomioka H, Sato K, Saito H. Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089 [Abstract] [Full Text] [Related]
18. In vitro susceptibility of Mycobacterium kansasii to the difluorinated quinolone sparfloxacin using a broth microdilution and macrodilution MIC system. Royo P, Martín-Casabona N, Martínez E, Andonegui M. Int J Tuberc Lung Dis; 1999 Apr; 3(4):349-53. PubMed ID: 10206507 [Abstract] [Full Text] [Related]
19. [In vitro antimycobacterial activity of a new quinolone, T-3761]. Tomioka H, Sato K, Saito H. Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982 [Abstract] [Full Text] [Related]
20. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium]. Ogawa K, Miwa T, Sasamoto M, Sasaki T, Tsuda M, Honda K, Furui H, Torii K, Takagi K. Kekkaku; 1992 Nov; 67(11):735-8. PubMed ID: 1487866 [Abstract] [Full Text] [Related] Page: [Next] [New Search]